Sabitlenmiş Tweet
AstraZeneca Medical US
14 posts

AstraZeneca Medical US
@AZMedical_US
The official Twitter feed for AstraZeneca US Medical. For more info visit https://t.co/vBjpqHjHkP
Wilmington, DE Katılım Haziran 2019
0 Takip Edilen129 Takipçiler

@W1Incognito The most common side effects for TEZSPIRE™ (tezepelumab-ekko) are sore throat, joint pain, and back pain. For more information about TEZSPIRE and its potential side effects, please see the full Important Safety Information here tezspire.com/safety-informa….
English

spr.ly/TEZSPIRERiskIn… Ask a doctor about TEZSPIRE, an add-on maintenance treatment for people with severe asthma. Not a rescue medicine.
English

@jjameson5141 @jjameson5141 We are sorry to hear that. We would like to learn more about their experience. Please call us at 1-800-236-9933.
English

tagrisso.az/Stage4Safety A diagnosis of stage 4 EGFR+ non-small cell lung cancer is the start of a purposeful treatment journey.
English

@AmongTheQuadi Hyperkalemia is a condition where there is too much potassium in your blood. For more information about LOKELMA, including safety, please talk to your doctor or visit at spr.ly/LokelmaPI
English

spr.ly/LOKELMASafetyI… We want to hear from you! Is a low K⁺ diet the only option to manage hyperkalemia in your patients?
English

@DarweeshHeiba The most common side effects for TEZSPIRE™ (tezepelumab-ekko) are sore throat, joint pain, and back pain. For more information about TEZSPIRE and its potential side effects, please see the full Important Safety Information here tezspire.com/safety-informa…
English

spr.ly/TEZSPIRERiskIn… Ask a doctor about TEZSPIRE, an add-on maintenance treatment for people with severe asthma. Not a rescue medicine.
English

@CthulhuBOINC There are no available data regarding the risk of infection with coronavirus disease (COVID-19) in patients being treated with TEZSPIRE™ (tezepelumab-ekko).
English

@CthulhuBOINC Hi, @CthulhuBOINC Be sure to talk to your healthcare provider if you have any questions about your health or medication. We understand your concern.
English

@UberFrood @UberFrood Twitter helps us deliver ads to people who may be interested. Although you can't opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more: help.twitter.com/en/safety-and-….
English

@lokelmahcp Why do you want to hear from me?
I don't even know what hyperkalemia is.
I could good it, but that still wouldn't make me qualified to answer your question.
Why don't you direct your advertisements at doctors?
English

@MistyKitty3 @MistyKitty3 Twitter helps us deliver ads to people who may be interested. Although you can't opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more: help.twitter.com/en/safety-and-….
English

spr.ly/LOKELMASafetyI… Learn about LOKELMA for the treatment of hyperkalemia in your patients on RAAS inhibitors.
English

Join us as heart failure expert Javed Butler, MD, MPH, MBA and Naeem Khan, MD, the VP of CVMD at AstraZeneca, co-lead a scientific discussion with HCPs about the increased risk of heart failure in patients with #T2D on 9/25, 8PM-9PM EST. Use #T2DHeartChat to participate.
English

@halShubin To learn more, please visit bit.ly/2Wykote.
English

@AZMedical_US If I see this ad, which I do, you’re marketing prescription drugs to patients. Why?
English

Join us on 9/25, 8PM-9PM EST for a scientific discussion with HCPs about the increased risk of heart failure in patients with #T2D, facilitated by heart failure expert Javed Butler, MD, MPH, MBA and Naeem Khan MD, the VP of CVMD at AstraZeneca. Use #T2DHeartChat to participate.
English

@Candy1967_ This account is intended for scientific discussion among healthcare professionals only. If you would like to report your experience, please call 1-800-236-9933. You can also visit
bit.ly/2ZEOUnI to check out our savings programs.
English

Join us on 9/25, 8PM-9PM EST for a scientific discussion with HCPs about the increased risk of heart failure in patients with #T2D, facilitated by heart failure expert Javed Butler, MD, MPH, MBA and Naeem Khan MD, the VP of CVMD at AstraZeneca. Use #T2DHeartChat to participate.
English




